Evidence map›Paper›PMID 41551644›Full record

ArticleFrontiers in microbiology2025

Pulmonary and extra-pulmonary infections caused by classical and hypervirulent

Fatma Alshehri, Rasha A Mosbah, Sozan M Abdelkhalig, Noaf Abdullah N Alblwi, Shereen Fawzy, Hanan Alshareef, Rehab Ahmed, Sawsan A Zaitone, Abir S Mohamed, Abdallah Tageldein Mansour and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fatma AlshehriDepartment of Biology, College of Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Rasha A MosbahInfection Control Unit, Zagazig University Hospital, Zagazig, Egypt.
Sozan M AbdelkhaligDepartment of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh, Saudi Arabia.
Noaf Abdullah N AlblwiAl Hadithah General Hospital, Al-Qurayyat, Saudi Arabia.
Shereen FawzyDepartment of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia.
Hanan AlshareefDepartment of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Rehab AhmedDivision of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Sawsan A ZaitoneDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Abir S MohamedDepartment of Public Health, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Abdallah Tageldein MansourDepartment of Fish and Animal Production, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa, Saudi Arabia.
Majid AlhomraniDepartment of Clinical Laboratories Sciences, The Faculty of Applied Medical Science, Taif University, Taif, Saudi Arabia.
Abdulhakeem S AlamriDepartment of Clinical Laboratories Sciences, The Faculty of Applied Medical Science, Taif University, Taif, Saudi Arabia.
Mahmoud M BendaryDepartment of Microbiology and Immunology, Faculty of Pharmacy, Port Said University, Port Said, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Methods and results: 600 clinical specimens were screened for Conclusion: The high MDR burden of cKp underscores the need for stronger antimicrobial stewardship and new therapies, while the invasive nature of hvKp highlights the importance of early recognition and rapid intervention to prevent systemic complications. Early distinction of cKp from hvKp can significantly influence treatment decisions and reduce morbidity and mortality associated with

Indexed as

carbapenem-resistant (CRKP)classical (cKp)extrapulmonary infectionshypervirulent (hvKp)Klebsiella pneumoniaemultidrug resistance (MDR)pulmonary infections

Identifiers

PMID41551644
PMCPMC12808397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.